| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:3704 | 6480464 | epigallocatechin gallate results in increased expression of SLC2A1 mRNA | CTD | PMID:16988119 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:737272 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A1 mRNA | CTD | PMID:22079256 |
| (S)-naringenin | multiple interactions | ISO | RGD:737272 | 6480464 | naringenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| (S)-naringenin | decreases activity | ISO | RGD:737272 | 6480464 | naringenin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:3704 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:17555576 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:3704 | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 more ... |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:17942748 PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:3704 | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:15576828 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:3704 | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:15901920 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:3704 | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:3704 | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:15901920 more ... |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:737272 | 6480464 | Estradiol results in increased expression of SLC2A1 protein | CTD | PMID:15350188 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737272 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein | CTD | PMID:15350188 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 protein | CTD | PMID:17872374 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737272 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA | CTD | PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737272 | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA]; more ... | CTD | PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3704 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:17872374 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:737272 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:17035482 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:737272 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:20106945 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:17872374 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:737272 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737272 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 PMID:17035482 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| 2-deoxy-2-((18)F)fluoro-D-glucose | multiple interactions | EXP | | 6480464 | [MRK 003 results in decreased expression of SLC2A1 protein] which results in decreased uptake of Fluorodeoxyglucose F18 | CTD | PMID:20197467 |
| 2-deoxy-2-((18)F)fluoro-D-glucose | affects uptake | ISO | RGD:737272 | 6480464 | SLC2A1 mRNA affects the uptake of Fluorodeoxyglucose F18 | CTD | PMID:16595493 |
| 2-deoxy-D-glucose | increases uptake | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased uptake of Deoxyglucose | CTD | PMID:2173694 |
| 2-deoxy-D-glucose | multiple interactions | EXP | | 6480464 | [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:737272 | 6480464 | SLC2A1 protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose] | CTD | PMID:2173694 |
| 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:737272 | 6480464 | Triiodothyronine results in increased expression of SLC2A1 mRNA | CTD | PMID:15507505 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC2A1 mRNA | CTD | PMID:20188158 |
| 3-methylcholanthrene | increases expression | ISO | RGD:3704 | 6480464 | Methylcholanthrene results in increased expression of SLC2A1 mRNA | CTD | PMID:21800402 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:3704 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of SLC2A1 mRNA | CTD | PMID:19162173 |
| 5-fluorouracil | decreases expression | ISO | RGD:737272 | 6480464 | Fluorouracil results in decreased expression of SLC2A1 mRNA | CTD | PMID:16253763 |
| 5-fluorouracil | decreases activity | ISO | RGD:737272 | 6480464 | Fluorouracil results in decreased activity of SLC2A1 protein | CTD | PMID:16253763 |
| 5-fluorouracil | increases expression | ISO | RGD:737272 | 6480464 | Fluorouracil results in increased expression of SLC2A1 mRNA | CTD | PMID:16595493 |
| acarbose | increases expression | ISO | RGD:3704 | 6480464 | Acarbose results in increased expression of SLC2A1 protein | CTD | PMID:11779583 |
| acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| aluminium atom | increases expression | ISO | RGD:737272 | 6480464 | Aluminum results in increased expression of SLC2A1 protein | CTD | PMID:16979867 |
| aluminium(0) | increases expression | ISO | RGD:737272 | 6480464 | Aluminum results in increased expression of SLC2A1 protein | CTD | PMID:16979867 |
| ammonium chloride | affects expression | ISO | RGD:3704 | 6480464 | Ammonium Chloride affects the expression of SLC2A1 mRNA | CTD | PMID:16483693 |
| anthracene-1,8,9-triol | increases expression | EXP | | 6480464 | Anthralin results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| arsenite(3-) | affects localization | EXP | | 6480464 | arsenite affects the localization of SLC2A1 protein | CTD | PMID:14511371 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
| ATP | decreases stability | ISO | RGD:737272 | 6480464 | Adenosine Triphosphate results in decreased stability of SLC2A1 protein | CTD | PMID:11420438 |
| benzaldehyde | increases activity | EXP | | 6480464 | benzaldehyde results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
| benzaldehyde | multiple interactions | EXP | | 6480464 | [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
| benzo[a]pyrene | affects expression | ISO | RGD:737272 | 6480464 | Benzo(a)pyrene affects the expression of SLC2A1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737272 | 6480464 | Benzo(a)pyrene results in decreased expression of SLC2A1 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SLC2A1 mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SLC2A1 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SLC2A1 mRNA | CTD | PMID:21715664 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| bisphenol A | increases expression | ISO | RGD:3704 | 6480464 | bisphenol A results in increased expression of SLC2A1 mRNA | CTD | PMID:15901920 PMID:12075121 |
| bisphenol A | increases expression | ISO | RGD:3704 | 6480464 | bisphenol A results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 PMID:15901920 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [Phospholipids results in increased localization of SLC2A1 protein] | CTD | PMID:15956784 |
| cadmium atom | increases expression | ISO | RGD:737272 | 6480464 | Cadmium results in increased expression of SLC2A1 mRNA | CTD | PMID:22562489 |
| cadmium dichloride | decreases expression | ISO | RGD:737272 | 6480464 | Cadmium Chloride results in decreased expression of SLC2A1 mRNA | CTD | PMID:12760830 |
| cadmium dichloride | increases expression | ISO | RGD:737272 | 6480464 | Cadmium Chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12160620 |
| cadmium dichloride | increases expression | ISO | RGD:3704 | 6480464 | Cadmium Chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19010381 |
| celecoxib | increases expression | ISO | RGD:737272 | 6480464 | celecoxib results in increased expression of SLC2A1 mRNA | CTD | PMID:19327236 |
| chloral hydrate | multiple interactions | ISO | RGD:737272 | 6480464 | Chloral Hydrate inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
| chloroform | increases expression | ISO | RGD:3704 | 6480464 | Chloroform results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of SLC2A1 mRNA | CTD | PMID:23125180 |
| cholic acid | increases expression | EXP | | 6480464 | Cholic Acid results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| cinnamyl alcohol | multiple interactions | EXP | | 6480464 | [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
| cinnamyl alcohol | increases activity | EXP | | 6480464 | cinnamyl alcohol results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
| ciprofloxacin | affects localization | ISO | RGD:737272 | 6480464 | Ciprofloxacin affects the localization of SLC2A1 mRNA | CTD | PMID:19022360 |
| ciprofloxacin | decreases expression | ISO | RGD:737272 | 6480464 | Ciprofloxacin results in decreased expression of SLC2A1 mRNA | CTD | PMID:19022360 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of SLC2A1 protein | CTD | PMID:22006019 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:7493931 |
| cobalt dichloride | increases expression | ISO | RGD:3704 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12819242 more ... |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:15525582 more ... |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12032628 more ... |
| cobalt dichloride | multiple interactions | ISO | RGD:737272 | 6480464 | [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC2A1 protein | CTD | PMID:17442736 |
| cobalt dichloride | increases expression | ISO | RGD:3704 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:15525582 more ... |
| cobalt dichloride | multiple interactions | ISO | RGD:3704 | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:18331222 PMID:19278353 |
| cobalt dichloride | multiple interactions | ISO | RGD:3704 | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 protein; more ... | CTD | PMID:19278353 |
| cobalt dichloride | increases expression | ISO | RGD:3704 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:19278353 PMID:20881034 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:11043581 |
| cobalt dichloride | increases expression | ISO | RGD:3704 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19278353 PMID:12819242 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | ARNT affects the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:11043581 |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:22202117 more ... |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:20526721 PMID:19808899 |
| cobalt dichloride | multiple interactions | ISO | RGD:737272 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein]; more ... | CTD | PMID:19808899 |
| cobalt dichloride | multiple interactions | ISO | RGD:737272 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:22202117 |
| cobalt dichloride | increases expression | ISO | RGD:737272 | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:7493931 PMID:22202117 |
| copper atom | multiple interactions | ISO | RGD:737272 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SLC2A1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:737272 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SLC2A1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | affects expression | ISO | RGD:737272 | 6480464 | Copper Sulfate affects the expression of SLC2A1 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | ISO | RGD:737272 | 6480464 | cupric chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:15741220 |
| corticosterone | increases expression | ISO | RGD:3704 | 6480464 | Corticosterone results in increased expression of SLC2A1 mRNA | CTD | PMID:15755911 |
| cumene | multiple interactions | EXP | | 6480464 | [cumene co-treated with KRAS gene mutant form] results in decreased expression of SLC2A1 mRNA | CTD | PMID:18648096 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of SLC2A1 mRNA | CTD | PMID:21397623 |
| cycloheximide | multiple interactions | ISO | RGD:737272 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SLC2A1 mRNA | CTD | PMID:19770486 |
| cytarabine | decreases expression | ISO | RGD:737272 | 6480464 | Cytarabine results in decreased expression of SLC2A1 mRNA | CTD | PMID:21198554 |
| D-glucose | multiple interactions | ISO | RGD:737272 | 6480464 | Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; more ... | CTD | PMID:18455367 |
| D-glucose | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; more ... | CTD | PMID:8895337 |
| D-glucose | multiple interactions | ISO | RGD:3704 | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
| D-glucose | multiple interactions | ISO | RGD:737272 | 6480464 | [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose | CTD | PMID:21265952 |
| D-glucose | multiple interactions | EXP | | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; more ... | CTD | PMID:20955755 |
| D-glucose | increases expression | ISO | RGD:737272 | 6480464 | Glucose results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
| D-glucose | increases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:8457197 PMID:18455367 |
| D-glucose | increases activity | EXP | | 6480464 | Glucose deficiency results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
| D-glucose | decreases expression | ISO | RGD:3704 | 6480464 | Glucose results in decreased expression of SLC2A1 mRNA | CTD | PMID:1727734 |
| D-glucose | multiple interactions | EXP | | 6480464 | oxophenylarsine inhibits the reaction [Glucose deficiency results in increased activity of SLC2A1 protein] | CTD | PMID:19686715 |
| D-glucose | increases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:18455367 PMID:8457197 |
| D-glucose | increases stability | ISO | RGD:737272 | 6480464 | Glucose results in increased stability of SLC2A1 protein | CTD | PMID:11420438 |
| D-glucose | multiple interactions | ISO | RGD:737272 | 6480464 | Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:8457197 |
| D-glucose | multiple interactions | ISO | RGD:737272 | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; more ... | CTD | PMID:14642735 |
| dacarbazine | decreases response to substance | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in decreased susceptibility to Dacarbazine | CTD | PMID:17520257 |
| daidzein | decreases activity | ISO | RGD:737272 | 6480464 | daidzein results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| daidzein | multiple interactions | ISO | RGD:737272 | 6480464 | daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| dehydroascorbic acid | decreases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein mutant form results in decreased transport of Dehydroascorbic Acid | CTD | PMID:11603379 |
| dehydroascorbic acid | affects transport | ISO | RGD:3704 | 6480464 | SLC2A1 protein affects the transport of Dehydroascorbic Acid | CTD | PMID:15590689 |
| dehydroascorbic acid | affects uptake | ISO | RGD:737272 | 6480464 | SLC2A1 mRNA affects the uptake of Dehydroascorbic Acid | CTD | PMID:16142743 |
| desferrioxamine B | increases expression | ISO | RGD:737272 | 6480464 | Deferoxamine results in increased expression of SLC2A1 mRNA | CTD | PMID:12032628 |
| desferrioxamine B | multiple interactions | ISO | RGD:737272 | 6480464 | [Deferoxamine results in decreased abundance of Oxygen] which results in increased expression of SLC2A1 protein | CTD | PMID:17442736 |
| dextran sulfate | increases expression | EXP | | 6480464 | Dextran Sulfate results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| diarsenic trioxide | increases expression | ISO | RGD:737272 | 6480464 | arsenic trioxide results in increased expression of SLC2A1 mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | increases import | ISO | RGD:3704 | 6480464 | SLC2A1 protein results in increased import of arsenic trioxide | CTD | PMID:17064664 |
| diarsenic trioxide | increases import | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased import of arsenic trioxide | CTD | PMID:17064664 |
| diazepam | multiple interactions | ISO | RGD:737272 | 6480464 | Diazepam inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of SLC2A1 mRNA | CTD | PMID:20003209 |
| dibenz[a,h]anthracene | increases expression | ISO | RGD:737272 | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of SLC2A1 mRNA | CTD | PMID:16269432 |
| dichloroacetic acid | decreases expression | EXP | | 6480464 | Dichloroacetic Acid results in decreased expression of SLC2A1 mRNA; more ... | CTD | PMID:22705712 |
| diethylstilbestrol | decreases activity | ISO | RGD:737272 | 6480464 | Diethylstilbestrol results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| diethylstilbestrol | multiple interactions | ISO | RGD:737272 | 6480464 | Diethylstilbestrol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| dioxygen | multiple interactions | ISO | RGD:737272 | 6480464 | 4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA]; more ... | CTD | PMID:19091749 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:20412331 PMID:20880076 |
| dioxygen | multiple interactions | EXP | | 6480464 | ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:20412331 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:20880076 |
| dioxygen | multiple interactions | ISO | RGD:3704 | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:18331222 PMID:19278353 |
| dioxygen | increases expression | ISO | RGD:3704 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:11524615 more ... |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:10780954 more ... |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 protein | CTD | PMID:15525582 more ... |
| dioxygen | multiple interactions | ISO | RGD:737272 | 6480464 | [Deferoxamine results in decreased abundance of Oxygen] which results in increased expression of SLC2A1 protein; more ... | CTD | PMID:17442736 |
| dioxygen | increases expression | ISO | RGD:3704 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 protein; more ... | CTD | PMID:11524615 PMID:19278353 |
| dioxygen | multiple interactions | ISO | RGD:3704 | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:19278353 |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 protein | CTD | PMID:19808899 |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:7493931 more ... |
| dioxygen | multiple interactions | ISO | RGD:737272 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein]; more ... | CTD | PMID:19808899 |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:7493931 PMID:10780954 |
| dioxygen | decreases response to substance | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in decreased susceptibility to Oxygen deficiency | CTD | PMID:10780954 |
| dioxygen | multiple interactions | ISO | RGD:737272 | 6480464 | SLC2A1 protein inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein] | CTD | PMID:10780954 |
| dioxygen | increases expression | ISO | RGD:737272 | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:10780954 PMID:7493931 |
| doxorubicin | increases expression | ISO | RGD:737272 | 6480464 | Doxorubicin results in increased expression of SLC2A1 mRNA | CTD | PMID:16595493 |
| doxorubicin | decreases expression | ISO | RGD:737272 | 6480464 | Doxorubicin results in decreased expression of SLC2A1 mRNA | CTD | PMID:22908232 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of SLC2A1 mRNA | CTD | PMID:21040762 |
| ethanol | decreases expression | ISO | RGD:3704 | 6480464 | Ethanol results in decreased expression of SLC2A1 mRNA | CTD | PMID:17920746 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SLC2A1 mRNA | CTD | PMID:19167417 |
| genistein | multiple interactions | ISO | RGD:737272 | 6480464 | Genistein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| genistein | increases expression | ISO | RGD:3704 | 6480464 | Genistein results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 |
| genistein | decreases activity | ISO | RGD:737272 | 6480464 | Genistein results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| gentamycin C | increases expression | EXP | | 6480464 | gentamicin C results in increased expression of SLC2A1 mRNA | CTD | PMID:12927799 |
| glucose | multiple interactions | ISO | RGD:737272 | 6480464 | Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]; more ... | CTD | PMID:18455367 |
| glucose | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; more ... | CTD | PMID:8895337 |
| glucose | multiple interactions | ISO | RGD:3704 | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
| glucose | multiple interactions | ISO | RGD:737272 | 6480464 | [PRNP protein results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose | CTD | PMID:21265952 |
| glucose | multiple interactions | EXP | | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; more ... | CTD | PMID:20955755 |
| glucose | increases expression | ISO | RGD:737272 | 6480464 | Glucose results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
| glucose | increases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:8457197 PMID:18455367 |
| glucose | increases activity | EXP | | 6480464 | Glucose deficiency results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
| glucose | decreases expression | ISO | RGD:3704 | 6480464 | Glucose results in decreased expression of SLC2A1 mRNA | CTD | PMID:1727734 |
| glucose | multiple interactions | EXP | | 6480464 | oxophenylarsine inhibits the reaction [Glucose deficiency results in increased activity of SLC2A1 protein] | CTD | PMID:19686715 |
| glucose | increases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:18455367 PMID:8457197 |
| glucose | increases stability | ISO | RGD:737272 | 6480464 | Glucose results in increased stability of SLC2A1 protein | CTD | PMID:11420438 |
| glucose | multiple interactions | ISO | RGD:737272 | 6480464 | Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:8457197 |
| glucose | multiple interactions | ISO | RGD:737272 | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose]; more ... | CTD | PMID:14642735 |
| hydrazine | increases expression | ISO | RGD:3704 | 6480464 | hydrazine results in increased expression of SLC2A1 mRNA | CTD | PMID:15370871 |
| hydrogen peroxide | affects expression | ISO | RGD:737272 | 6480464 | Hydrogen Peroxide affects the expression of SLC2A1 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | decreases expression | ISO | RGD:737272 | 6480464 | Hydrogen Peroxide results in decreased expression of SLC2A1 protein | CTD | PMID:21179406 |
| ibuprofen | decreases expression | ISO | RGD:737272 | 6480464 | Ibuprofen results in decreased expression of SLC2A1 protein | CTD | PMID:12912967 |
| iron dichloride | increases expression | EXP | | 6480464 | ferrous chloride results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| isoliquiritigenin | multiple interactions | ISO | RGD:737272 | 6480464 | isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| isoliquiritigenin | decreases activity | ISO | RGD:737272 | 6480464 | isoliquiritigenin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of SLC2A1 mRNA | CTD | PMID:20003209 |
| kaempferol | decreases activity | ISO | RGD:737272 | 6480464 | kaempferol results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| kaempferol | multiple interactions | ISO | RGD:737272 | 6480464 | kaempferol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| L-ascorbic acid | increases expression | ISO | RGD:3704 | 6480464 | Ascorbic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:15372504 |
| L-cysteine | multiple interactions | EXP | | 6480464 | Cysteine inhibits the reaction [[cinnamic aldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] | CTD | PMID:20955755 |
| L-dehydroascorbic acid | decreases transport | ISO | RGD:737272 | 6480464 | SLC2A1 protein mutant form results in decreased transport of Dehydroascorbic Acid | CTD | PMID:11603379 |
| L-dehydroascorbic acid | affects transport | ISO | RGD:3704 | 6480464 | SLC2A1 protein affects the transport of Dehydroascorbic Acid | CTD | PMID:15590689 |
| L-dehydroascorbic acid | affects uptake | ISO | RGD:737272 | 6480464 | SLC2A1 mRNA affects the uptake of Dehydroascorbic Acid | CTD | PMID:16142743 |
| lead(0) | decreases expression | ISO | RGD:3704 | 6480464 | Lead results in decreased expression of SLC2A1 protein | CTD | PMID:22129743 |
| lead(0) | multiple interactions | ISO | RGD:3704 | 6480464 | Plant Extracts inhibits the reaction [Lead results in decreased expression of SLC2A1 protein] | CTD | PMID:22129743 |
| lithocholic acid | increases expression | EXP | | 6480464 | Lithocholic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| LY294002 | multiple interactions | ISO | RGD:737272 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein]; more ... | CTD | PMID:19808899 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phospholipids results in increased localization of SLC2A1 protein] | CTD | PMID:15956784 |
| menadione | affects expression | ISO | RGD:737272 | 6480464 | Vitamin K 3 affects the expression of SLC2A1 mRNA | CTD | PMID:20044591 |
| mercaptoethanol | multiple interactions | EXP | | 6480464 | Mercaptoethanol inhibits the reaction [[cinnamic aldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] | CTD | PMID:20955755 |
| methylarsonic acid | increases import | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in increased import of monomethylarsonic acid | CTD | PMID:17064664 |
| methylarsonic acid | increases import | ISO | RGD:3704 | 6480464 | SLC2A1 protein results in increased import of monomethylarsonic acid | CTD | PMID:17064664 |
| methylene blue | multiple interactions | EXP | | 6480464 | oxophenylarsine inhibits the reaction [Methylene Blue results in increased activity of SLC2A1 protein] | CTD | PMID:19686715 |
| methylene blue | increases activity | EXP | | 6480464 | Methylene Blue results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
| methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of SLC2A1 protein | CTD | PMID:15649634 |
| myricetin | multiple interactions | ISO | RGD:737272 | 6480464 | myricetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| myricetin | decreases activity | ISO | RGD:737272 | 6480464 | myricetin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of SLC2A1 mRNA | CTD | PMID:17475336 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12839937 |
| nickel dichloride | multiple interactions | EXP | | 6480464 | HIF1A affects the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:12426141 PMID:12729255 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12729255 more ... |
| nickel dichloride | increases expression | ISO | RGD:3704 | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:22110744 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12426141 more ... |
| nickel dichloride | multiple interactions | EXP | | 6480464 | HIF1A affects the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:12729255 PMID:12426141 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of SLC2A1 mRNA | CTD | PMID:16100012 |
| nimesulide | multiple interactions | EXP | | 6480464 | SLC2A1 inhibits the reaction [nimesulide results in increased uptake of Hexoses] | CTD | PMID:16447059 |
| ofloxacin | affects localization | ISO | RGD:737272 | 6480464 | Ofloxacin affects the localization of SLC2A1 mRNA | CTD | PMID:19022360 |
| ofloxacin | decreases expression | ISO | RGD:737272 | 6480464 | Ofloxacin results in decreased expression of SLC2A1 mRNA | CTD | PMID:19022360 |
| okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| paracetamol | increases expression | ISO | RGD:3704 | 6480464 | Acetaminophen results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC2A1 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:3704 | 6480464 | Paraquat results in increased expression of SLC2A1 mRNA | CTD | PMID:18198484 |
| pentobarbital | multiple interactions | ISO | RGD:737272 | 6480464 | Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose]; more ... | CTD | PMID:10590023 |
| pentobarbital | decreases activity | ISO | RGD:737272 | 6480464 | Pentobarbital results in decreased activity of SLC2A1 protein | CTD | PMID:10590023 |
| phenobarbital | multiple interactions | ISO | RGD:737272 | 6480464 | Phenobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose]; more ... | CTD | PMID:10590023 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of SLC2A1 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| phenobarbital | affects expression | ISO | RGD:737272 | 6480464 | Phenobarbital affects the expression of SLC2A1 mRNA | CTD | PMID:19159669 |
| phenobarbital | decreases activity | ISO | RGD:737272 | 6480464 | Phenobarbital results in decreased activity of SLC2A1 protein | CTD | PMID:10590023 |
| phenylephrine | increases expression | ISO | RGD:3704 | 6480464 | Phenylephrine results in increased expression of SLC2A1 mRNA | CTD | PMID:15808844 |
| phloretin | multiple interactions | ISO | RGD:737272 | 6480464 | Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| phloretin | decreases activity | ISO | RGD:737272 | 6480464 | Phloretin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:17426115 |
| progesterone | multiple interactions | ISO | RGD:737272 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein | CTD | PMID:15350188 |
| progesterone | increases expression | ISO | RGD:737272 | 6480464 | Progesterone results in increased expression of SLC2A1 protein | CTD | PMID:15350188 |
| propanal | multiple interactions | EXP | | 6480464 | [propionaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
| propanal | increases activity | EXP | | 6480464 | propionaldehyde results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
| quercetin | multiple interactions | ISO | RGD:737272 | 6480464 | Quercetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| quercetin | decreases activity | ISO | RGD:737272 | 6480464 | Quercetin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| ranitidine | multiple interactions | ISO | RGD:3704 | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] | CTD | PMID:16415329 |
| rosiglitazone | decreases expression | ISO | RGD:737272 | 6480464 | rosiglitazone results in decreased expression of SLC2A1 mRNA | CTD | PMID:17148569 |
| rosiglitazone | affects expression | EXP | | 6480464 | rosiglitazone affects the expression of SLC2A1 mRNA | CTD | PMID:22013433 |
| rotenone | multiple interactions | ISO | RGD:737272 | 6480464 | SLC2A1 protein inhibits the reaction [Rotenone results in increased activity of MAPK8 protein] | CTD | PMID:10780954 |
| rotenone | decreases response to substance | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in decreased susceptibility to Rotenone | CTD | PMID:10780954 |
| rotenone | multiple interactions | ISO | RGD:737272 | 6480464 | Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:19091749 |
| saccharin | increases expression | EXP | | 6480464 | Saccharin results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| sodium azide | increases expression | EXP | | 6480464 | Sodium Azide results in increased expression of SLC2A1 mRNA | CTD | PMID:14578187 |
| sodium chloride | increases expression | EXP | | 6480464 | Sodium Chloride results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
| sodium dichromate | decreases expression | ISO | RGD:737272 | 6480464 | sodium bichromate results in decreased expression of SLC2A1 mRNA | CTD | PMID:12760830 |
| streptozocin | multiple interactions | ISO | RGD:3704 | 6480464 | Drugs, Chinese Herbal inhibits the reaction [Streptozocin results in increased expression of SLC2A1 mRNA] | CTD | PMID:16409969 |
| streptozocin | increases expression | ISO | RGD:3704 | 6480464 | Streptozocin results in increased expression of SLC2A1 mRNA | CTD | PMID:16409969 |
| sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
| tamoxifen | multiple interactions | ISO | RGD:737272 | 6480464 | Tamoxifen inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of SLC2A1 mRNA | CTD | PMID:17555576 |
| tamoxifen | decreases activity | ISO | RGD:737272 | 6480464 | Tamoxifen results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of SLC2A1 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | ISO | RGD:3704 | 6480464 | Carbon Tetrachloride results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
| tetracycline | increases expression | ISO | RGD:3704 | 6480464 | Tetracycline results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
| tolbutamide | increases expression | EXP | | 6480464 | Tolbutamide results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:11835228 PMID:2682625 |
| tolbutamide | increases expression | EXP | | 6480464 | Tolbutamide results in increased expression of SLC2A1 protein; more ... | CTD | PMID:2682625 PMID:11835228 |
| troglitazone | increases expression | ISO | RGD:737272 | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA | CTD | PMID:9544743 PMID:9589670 |
| troglitazone | decreases expression | ISO | RGD:737272 | 6480464 | troglitazone results in decreased expression of SLC2A1 mRNA | CTD | PMID:11162573 |
| troglitazone | increases expression | ISO | RGD:737272 | 6480464 | troglitazone results in increased expression of SLC2A1 protein | CTD | PMID:9589670 |
| troglitazone | increases expression | ISO | RGD:3704 | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA | CTD | PMID:10726906 |
| troglitazone | multiple interactions | ISO | RGD:3704 | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA; more ... | CTD | PMID:8895337 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; more ... | CTD | PMID:8895337 |
| valproic acid | multiple interactions | ISO | RGD:737272 | 6480464 | Valproic Acid inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
| valproic acid | multiple interactions | ISO | RGD:3704 | 6480464 | [Valproic Acid co-treated with Lipopolysaccharides] results in decreased expression of SLC2A1 protein | CTD | PMID:16902764 |
| valproic acid | affects expression | ISO | RGD:3704 | 6480464 | Valproic Acid affects the expression of SLC2A1 protein | CTD | PMID:16902764 |
| vincristine | decreases response to substance | ISO | RGD:737272 | 6480464 | SLC2A1 protein results in decreased susceptibility to Vincristine | CTD | PMID:17520257 |
| zinc dichloride | multiple interactions | ISO | RGD:737272 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:22202117 |
| zinc dichloride | increases expression | EXP | | 6480464 | zinc chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |